Development and validation of a fast RP-HPLC method for the determination of clobetasol propionate in topical nanocapsule suspensions.
(58/406)
A simple and rapid high-performance liquid chromatographic method is validated for the determination of clobetasol propionate in topical nanocapsule suspensions. The method is carried out on an RP-18 column with a mobile phase composed of methanol-water (80:20 v/v) and UV detection at 241 nm. The method validation yields good results with respect to linearity, specificity, precision, accuracy, and robustness. The calibration curve in the range of 5.0-40.0 microg/mL shows a correlation coefficient of 0.9999. Precision (intra-day and inter-day) is demonstrated by a relative standard deviation lower than 1.5%. Accuracy is assessed by the recovery test of clobetasol propionate from sample matrixes (98.33 +/- 0.88%). In conclusion, the method is suitable to be applied to assay clobetasol propionate in topical formulations of polymeric nanocapsules, avoiding the use of a buffer solution in the mobile phase. (+info)
Analysis of process parameters affecting spray-dried oily core nanocapsules using factorial design.
(59/406)
Firstborn microcrystallization method to prepare nanocapsules containing artesunate.
(64/406)
We developed a novel method to prepare nanocapsules. A solute often crystallizes when its solubility alters from one solvent to another, and its firstborn crystals are used as templates to prepare nanocapsules for the first time, which is called firstborn microcrystallization method. By using this method, the maximum diameter of the nanocapsules including artesunate is about 76 nm, and wrapping state is well. One important advantage of our method is that the preparation of the nanocapsules operates easily and is a one-time process with no other cumbersome processes necessary, therefore avoiding secondary pollution. The proposed method provides a new route to prepare monodisperse nanocapsules to increase bioavailability of hydrophobic solutes. (+info)